International Point of Care Incorporated (iPOC), based in Toronto, Canada, is a leading provider of innovative solutions for the in-vitro diagnostic industry and research and development community. With a strong focus on rapid point-of-care testing, we offer contract IVD manufacturing, lateral flow components (including our advanced PrimeCare™ blood separation membrane), and custom lyophilization services. Our ISO 13485-certified 36,000 sq. ft. facility is equipped to meet the demands of commercial-scale production. This enables us to deliver high-capacity, custom-configured lyophilized beaded reagents (LBRs) to our global healthcare clientele, ensuring compliance, quality, and rapid market entry while accommodating increasing production volumes.